Contraindicated (1)bortezomib will raise the stage or result of mavacamten by influencing hepatic enzyme CYP2C19 metabolism. Contraindicated. Strong or moderate CYP2C19 inhibitors could improve mavacamten systemic exposure, resulting in heart failure as a result of systolic dysfunction. Adult males making use of this medication should really request about trusted forms https://maoecrystal-b87654.blogminds.com/detailed-notes-on-retene-24581560